Comprehensive guides on mass tort lawsuits including eligibility, settlement amounts, and how to file a claim with an experienced attorney.
Updates on Mass Tort Lawsuits
Decades of scientific research, the IARC's 2024 Group 1 carcinogen reclassification, and J&J's failed bankruptcy attempts have reshaped the talcum powder lawsuit landscape in 2026. Learn what the science says, who qualifies, what settlements look like, and how to file a claim.
Texas Depo-Provera Meningioma Claim Guide Depo-Provera Lawsuit Texas 2026: Eligibility, Deadlines and How to File If you live in Texas and developed an intracranial meningioma after receiving Depo-Provera or a generic depot medroxyprogesterone acetate injection, a Depo-Provera Lawsuit Texas review may help determine whether you can join the federal litigation. This Texas-focused guide explains how [...]
In This Article What Is This Lawsuit? The Science: Depo-Provera and Meningioma Risk Settlement Amounts 2026 Who Qualifies? Pfizer's Liability How to File Filing Deadlines by State Latest Litigation Updates Frequently Asked Questions The depo provera brain tumor lawsuit has become one of the largest pharmaceutical mass tort actions of 2026, with more than 3,700 [...]
In This Article What Is the Talcum Powder Lawsuit? Health Risks Linked to Talcum Powder Talcum Powder Settlement Amounts in 2026 Who Qualifies for a Talcum Powder Lawsuit? Johnson & Johnson Bankruptcy Update 2026 How to File a Talcum Powder Lawsuit Claim Statute of Limitations: Act Before Time Runs Out Talcum Powder Lawsuit Timeline Infographic [...]
Understand delayed breast cancer diagnosis causes, risks, and how to act fast for better outcomes.
Quick Answer: The talcum powder lawsuit update for 2026 centers on Johnson & Johnson's proposed $6.48 billion bankruptcy settlement fund for 62,000+ claimants. Courts rejected J&J's earlier bankruptcy strategy twice, and a new claimant vote is underway. Women diagnosed with ovarian cancer, mesothelioma, or related cancers after long-term talcum powder use may qualify. Settlement payouts [...]
Short answer: Depo-Provera (medroxyprogesterone acetate) has been linked to an elevated risk of intracranial meningioma — a type of brain tumor. Over 12,000 lawsuits have been filed against Pfizer as of 2026, consolidated into a federal MDL in the Northern District of Illinois. Women who used Depo-Provera for one year or more and later developed [...]
-
Tupelo hair relaxer cancer lawsuit victims: Get legal help to claim compensation for uterine/ovarian cancer linked to products. Act now!
-
Stay updated on Monsanto lawsuit news. Discover billions in verdicts, settlements, cancer links, and your legal options for claims.
🗓 Last Updated: May 2026 ✅ Reviewed by: TortAdvisor Editorial Team 📚 Sources: FDA, Federal Court, BMJ, PubMed ⚖️ Topic: Depo-Provera MDL No. 3140 What You Need To Know About Depo-Provera Lawsuit Settlements in 2026 What You Need To Know About Depo-Provera Lawsuit Settlements in 2026 is that no global settlement has been announced, [...]
-
WTC lawsuit 2026 guide covering 9/11 Victim Compensation Fund updates, who qualifies, settlements $10K–$5M+, and step-by-step filing. Free review: 1 (855) 664-8713.
-
Depo-Provera lawsuit update May 2026: MDL 3140 at 3,769+ cases, Daubert hearings active, statutes of limitations running. Who qualifies, settlement amounts. Call 1 (855) 664-8713.
-
Can you sue Depo-Provera for meningioma? Yes — 3,769+ cases in MDL 3140 against Pfizer. Eligibility, settlement amounts $50K–$500K+, how to file for free. Call 1 (855) 664-8713.
-
Depo-Provera meningioma lawsuit 2026: FDA-confirmed link between Depo-Provera and meningioma brain tumors. 3,769+ cases in MDL 3140. Who qualifies, settlement amounts, and how to file. Call 1 (855) 664-8713.
The Depo-Provera lawsuit 2026 is at a critical juncture with 3,790+ meningioma cases in MDL 3140 awaiting Daubert rulings. Learn who qualifies, settlement estimates, and how to file your claim before the deadline.
